The effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) are not confined to cells of the myeloid lineage. GM-CSF has been shown to have effects on mature T cells and both mature and immature T-cell lines. We therefore examined the GM-CSF responsiveness of murine thymocytes to investigate whether GM-CSF also affected normal immature T lymphocytes. The studies presented here indicate that GM-CSF augments accessory cell (AC)-dependent T-cell receptor (TCR)-mediated proliferation of unseparated thymocyte populations. To identify the GM-CSF responsive cell type, thymic AC and T cells were examined for GM-CSF responsiveness. We found that GM-CSF augmentation of TCR-induced thymocyte proliferation
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Blood. Vol83, No 3 (February l), 1994: pp 7 13-723 appears to be mediated via augmentation of AC function, and not via direct effects on mature single-positive (SP) thymocytes. Enriched double-negative (DN) thymocytes were also tested for GM-CSF responsiveness. GM-CSF induced the proliferation of adult and fetal DN thymocytes in an AC-independent and TCR-independent single-cell assay. Thus, in contrast to the SP thymocytes, a DN thymocyte population was directly responsive to GM-CSF. GM-CSF therefore may play a direct role in the expansion of DN thymocytes and an indirect role in the expansion of SP thymocytes.
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that GM-CSF may have direct or indirect effects on mature cells of the T lineage. TALL-101, a human leukemia with an immature T-cell phenotype, grows in response to GM-CSF,22 raising the possibility that GM-CSF may also affect T-lineage cells at earlier stages of development. To determine if GM-CSF influenced normal immature T cells, we examined the effect of GM-CSF on both the T-cell receptor (TCR)-dependent proliferation of adult thymocytes and the TCR-independent proliferation of DN-enriched adult and fetal thymocytes. Our results suggest that GM-CSF represents an important regulatory cytokine in thymocyte differentiation.
MATERIALS AND METHODS
Animals. Six to 12-week-old C57BL/6J (B6) mice (Jackson Laboratories, Bar Harbor, ME) of either sex were used. B6 mice were bred in our animal facility to obtain fetal mice. Pregnancies were timed, and day 0 was defined as the day that a vaginal plug was observed. All animals were housed in a specific pathogen-free animal facility, and provided with Purina rodent chow and tap water ad libitum. Animals were killed by cervical dislocation or CO2
inhalation.
Medium. RPM1 1640 (GIBCO, Grand Island, NY) was supplemented with 50 to 75 rmol/L 2-mercaptoethanol (GIBCO), 2 to 2.4 mmol/L glutamine (GIBCO), 8 to 10 U/mL penicillin, and 8 to 10 pg/mL streptomycin (GIBCO), and 10% heat inactivated fetal 714 STEWART-AKERS ET AL bovine serum (FBS; GIBCO) , hereafter referred to as complete medium (CM).
Cytokines and antibodies. Human recombinant (r)IL-2 (specific activity, 3 X IO6 U/mg) was donated by Cetus Oncology (Emeryville, CA). COS 7 supernatant containing murine GM-CSF was the generous gift of DNAX Research Institute (Palo Alto, CA) or was produced by us as described p r e v i~u s l y .~~ Murine rGM-CSF (specific activity, 5 X IO7 colony-forming units-committed [CFUc]/mg) was purchased from Genzyme (Boston, MA) and used both in experiments and as a standard for titrating the other murine GM-CSF-containing material on the GM-CSF-dependent cell line DA3. I 5.24 Anti-CD4 monoclonal antibody (MoAb) (clone RL/ 172),25 anti-IL-2 receptor a chain MoAb (clone 7D4),26 anti-IL-4 MoAb (clone I IBI l ) : ' anti-la MoAb (clone BP107.2.2),28 and J I ld.2 MoAbZ9 were used as hybridoma culture supernatants. Anti-CD8 MoAb was used as ascites fluid (clone 3.1 55)30 or culture supernatant (clone 3.168)." Anti-CD3 MoAb (clone 145-2C 1 I)" was used as hybridoma culture supernatant and as protein A-purified material. Anti-Fc receptor MoAb (clone 2.4G2)32 was used as protein A-purified material. Goat anti-mouse GM-CSF polyclonal anti~erum'~ was a gift from DNAX Research Institute. Hamster antimurine IFN--, MoAb was purchased from Genzyme. Rat antimouse TNF-a MoAb was purchased from PharMingen (San Diego, CA). The following fluorescent-tagged antibodies were used as indicated: goat anti-rat (GAR) immunoglobulin-fluorescein isothiocyanate (FITC) (Caltag, South San Francisco, CA); anti-CD8-FITC (Becton Dickinson, Mountain View, CA); anti-CD4-PE (Becton Dickinson); anti-Thy-I -FITC (Becton Dickinson); Leu-4-FITC (antihuman CD3) (Becton Dickinson); and Leu-4-phycoerythrin (Becton Dickinson).
C'omi/ogenicus.say. Single-cell suspensions of thymocytes were obtained by gentle abrasion ofthe thymus on a sterile stainless steel screen and were washed twice in phosphate-buffered saline (PBS) plus 5 8 fetal bovine serum (FBS) before use. Thymocytes were cultured at 3 x IO5 cells per well in CM in flat-bottom microtiter plates (GIBCO) in the presence or absence of anti-CD3 MoAb hybridoma culture supernatant or Concanavalin (Con) A (Sigma, St Louis, MO). as indicated. Cytokines and additional antibodies were added as indicated. The plates were incubated at 37°C in 5% CO2 for 4 days unless indicated otherwise. The cultures were labeled with 1 pCi of 'H-thymidine (NEN, Dupont, Boston, MA) for the last 18 hours of culture. The plates were harvested onto glass-fiber filters with a semiautomated cell harvester to which I mL of Cytoscint scintillation fluid (ICN Biomedical, Irvine, CA) was added, and the samples were counted on a beta-counter. The values shown are the mean * SD of triplicate cultures.
Kinetic experiments. For addition experiments, thymocytes were plated into microtiter plates at 3 X 105/well in the presence of 1.25 pg/mL Con A. GM-CSF 100 U/mL or medium was added at 0, I , 2. or 3 days. The cultures were labeled for the last 18 hours of culture and harvested on day 4 as described above.
For subtraction experiments. I X IO6 thymocytes were cultured in I mL of CM in the presence of 1.25 pg/mL Con A or the combination of ( I .25 pg/mL Con A + 100 U/mL GM-CSF) in 24-well plates (GIBCO) for 0, I , 2, or 3 days. The cells were harvested. washed to remove excess factors, and recultured at 3 X 10' (assuming no cell loss) in microtiter plates in CM in the presence or absence of I .25 pg/mL Con A for the remainder ofthe 4-day culture period. Anti-GM-CSF antiserum at a concentration of 0.1% was added to cells recultured in Con A to neutralize residual GM-CSF. The CUItures were labeled for the last 18 hours of culture and harvested on day 4 as described above.
Flow-cylometric analysis of'thymocyte cultures. Thymocytes, 5 X 106/mL. were cultured in the presence of 1.25 pg/mL Con A or (0.01% anti-CD3 MoAb hybridoma supernatant + 20 U/mL 1L-2) in CM in 25-cm2 tissue culture flasks (GIBCO). GM-CSF 100 U/ mL was added as indicated. Cells were harvested at the times indicated, and viable cells were recovered by separation on Lympholyte M (Cedarlane, Accurate, Westbury, NY). After extensive washing. the cells were stained with anti-CD4-PE, anti-CD8-FITC, or anti-IL-2 receptor a chain (1L-2R) MoAb for 30 minutes at 4°C. Anti-IL-2R MoAb was followed by a 30-minute incubation at 4°C with GAR-FITC before analysis. A total of 5 X IO' events were collected on a FACStar (Becton Dickinson) or FACStar Plus (Becton Dickinson). Viable cells based on forward and 90" angle light scatter were analyzed with logarithmic signal amplification.
Acce.uory cell enrichment protocol. A thymocyte accessory cell (AC)-enriched population was obtained by treating thymocytes at 5 X IO7 cells/mL with a 1:20 dilution of anti-CD4 MoAb hybridoma supernatant and a I :20 dilution of anti-CD8 MoAb hybridoma supernatant for 30 minutes on ice. The cells were then spun down, washed once, and resuspended in a 1:20 dilution of rabbit complement (Cedarlane). The cells were incubated for an additional 45 minutes at 37°C. The cells were washed extensively, and viable cells were recovered by separation on Lympholyte M and cultured in 100 U/mL GM-CSFor medium in 24-well plates for 24 hours. After 24 hours, the cultured AC-enriched cells were harvested, washed, counted, irradiated (3.000 rad), and added to freshly isolated thymocytes enriched for responder cells (see following) (3 X 105/well) in the presence of 1.25 pg/mL Con A in 96-well plates. The cultures were incubated for an additional 3 days and labeled with I pCi 'Hthymidine for the last l8 hours of the culture period.
The thymocyte responder population was depleted of most ACs by passage on nylon wool (NW) essentially as described prev i o~s l y .~~
The NW-nonadherent cells were further treated with a I: 2 dilution of anti-la MoAb (anti-MHC class 11) hybridoma supernatant for 30 minutes on ice followed by a 45-minute incubation with a 1:20 dilution of rabbit complement at 37°C. The cells were washed extensively and viable cells were recovered by separation on Lympholyte M.
Prepururion o / WII populution.s/i)r microcullur(, assuy. For SP enrichment. thymocytes were incubated at 5 X IO'cells/mL with a 1:2 dilution o f J l ld.2 MoAb hybridoma supernatant for 15 minutes on ice. A 120 dilution of rabbit complement was added and the cells were incubated for an additional 45 minutes at 37°C. The MoAb and complement treatment was repeated. The cells were washed extensively and viable cells were recovered by separation on Lympholyte M. An aliquot of the cells was stained with anti-CD8-FITC and anti-CD4-PE and analyzed by flow cytometry to verify enrichment of SP thymocytes.
For DN enrichment, thymocytes were incubated at 5 X 10' cells/ mL with a I :2 dilution of anti-CD4 MoAb hybridoma supernatant and a I: 1,000 dilution of anti-CD8 MoAb ascites plus either a 1: 10 dilution of rabbit complement or a 1.5 dilution of guinea pig complement (GIBCO) for 30 minutes at 37°C. Cells were then spun down and resuspended in fresh complement in one half the initial volume with 0. I mg/mL DNase (Sigma) and incubated for an additional 30 minutes at 37°C. The cells were then washed twice before use. Depletion of CD4+ and CD8+ cells was verified by immunofluorescence and flow cytometry using the original depleting MoAbs, followed by GAR-FITC. In some experiments, the cells were also stained with anti-Thy-I-FITC. Nonspecific binding of anti-Thy-l-FlTC was inhibited by adding anti-Fc receptor MoAb to the cells approximately 2 minutes before adding anti-Thy-l-FITC MoAb.
For fetal thymocytes, single-cell suspensions of 14-day fetal thymic lobes were prepared in PBS plus 5% FBS with a microtissue grinder, followed by one or two passages through a 23-gauge needle.
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The cells were washed twice and counted before use. In some experiments, the cells were stained with anti-CM-PE, anti-CD8-FITC, and anti-Thy-1-FITC.
Microculture assay. Single-cell suspensions of the cell populations described above were prepared at 160 cells/mL with additives at the indicated concentrations in CM further supplemented with 10 mmol/L of nonessential amino acids (GIBCO) and 1 mmol/L of sodium pyruvate (GIBCO). Ten microliters of the cell suspensions was plated in each well of a Terasaki plate (60-well HL-A plate; Nunc, Naperville, IL). For some experiments, anti-CD3 MoAb was linked to the plates by preincubating 10 pL of purified anti-CD3 MoAb, at the concentrations indicated, in 50 mmol/L of Tris, pH 8.8, for at least I hour at RT. The plates were washed twice with PBS and once with PBS plus 2% FBS before use.
After the cells were distributed, the plates were spun at 750g for 5 minutes to pellet the cells, after which each well was examined microscopically (200X magnification on an Olympus BH-2 microscope). Only wells containing one cell were included in subsequent analyses. The plates were incubated at 37°C in 10% CO2 in minihumidity chambers, constructed from square Petri dishes (Falcon), with PBS-saturated sterile gauze strips in the bottom. At the times indicated, wells were reexamined microscopically for proliferation. A well was scored positive if it contained more than one cell. This assay has been shown to be sensitive enough to detect the effects of cytokines on single cells. 35 Statistical analysis of these experiments was performed using a chi-square test. Results were considered statistically significant at P 5 .05.
RESULTS

Characterization of GM-CSF augmentation of TCR-mediated thymocyte proliferation.
A number of stimuli, including antibodies to the TCR/CD3 complex and the mitogen Con A, can be used to mimic the antigen-MHC engagement of TCR on T cells or thymocytes and induce proliferation. Murine thymocytes proliferated in a concentration-dependent manner to soluble anti-CD3 MoAb ( Fig  1A) . In the presence of a submitogenic concentration of anti-CD3 MoAb (0.15%), IL-2 augmented thymocyte proliferation in a concentration-dependent manner (Fig I B) . GM-CSF augmented thymocyte proliferation when added to cultures containing suboptimal concentrations of both anti-CD3 (0.15%) and 1L-2 (0.5 U/mL) ( Fig 1C) . GM-CSF also augmented anti-CD3-dependent proliferation in the presence of optimal IL-2 concentrations (data not shown), suggesting that GM-CSF does not act by inducing IL-2 production in these cultures. In the absence ofanti-CD3 MoAb, neither IL-2 nor GM-CSF, alone or together, induced thymocyte proliferation (Fig 1 C) . These observations are consistent with reports that adult thymocyte responses to a number of cytokines, including IL-1, IL-2, IL-4, and IL-6,3 require a costimulus.
GM-CSF also augmented the Con A-induced proliferation of murine thymocytes (Fig 2A) . This augmentation was seen only at mitogenic concentrations of Con A; when Con A was used at submitogenic concentrations, no augmentation by GM-CSF was seen (Fig 2A) . Furthermore, when GM-CSF was added in the absence of Con A, no thymocyte proliferation was measured (Fig 2A) . At a suboptimal, but mitogenic concentration of Con A (1.25 pg/mL), augmentation of the thymocyte response by GM-CSF was dose&-pendent, with augmentation consistently measured at 100 For personal use only. on November 11, 2017. by guest www.bloodjournal.org From (a) and absence (0) of GM-CSF. Con A was used at the concentrations indicated, and GM-CSF was used at 100 U/mL. The cultures were labeled forthe last 18 hours of a 4-day culture period. (B) Thymocytes were cultured in the absence (No Con A) or presence of 1.25 pg/mL of Con A and the indicated concentrations of GM-CSF. The cultures were labeled for the last 18 hours of a 4-day culture period. (C) Thymocytes were cultured with Con A or Con A plus GM-CSF, as indicated, in the absence (U) or presence (B) of anti-GM-CSF antiserum. Con A was used at 1.25 pg/mL, GM-CSF was used at 100 U/mL, and anti-GM-CSF antiserum was used at 0.1 %.
Each panel depicts a separate experiment. U/mL GM-CSF (Fig 2B) . An anti-GM-CSF antiserum at a concentration of 0.1 % inhibited GM-CSF augmentation of Con A-induced thymocyte proliferation, but not basal Con A-induced proliferation (Fig 2C) . Normal goat serum did not inhibit thymocyte proliferation induced by Con A or by Con A plus GM-CSF (data not shown).
The kinetics of thymocyte proliferation were compared in cultures stimulated with either Con A or Con A plus GM-CSF (Fig 3) . No differences were found in either the time at which proliferation was first detectable, day 3 (Fig 3A) , or the time at which peak levels of proliferation occurred, days 4 and 5 ( Fig 3B) . Thus, GM-CSF does not appear to augment Con A-induced thymocyte proliferation by altering the kinetics of the proliferative response.
To define the period in the Con A comitogenic assays when GM-CSF was required, GM-CSF was added to, or removed from, cultures at various times. To induce an enhanced response in a 4-day culture, GM-CSF was required at the initiation of culture. Addition of GM-CSF on day I , 2, or 3 failed to induce greatly augmented proliferation ( Fig  4A) . In reciprocal experiments, thymocytes were stimulated with Con A or Con A plus GM-CSF on day 0: on day 0 (immediately after set up), and on day I , 2, and 3 of culture, samples were harvested, washed to remove additives, and recultured in Con A or medium for the remainder of the 4-day culture period. Anti-GM-CSF antiserum was added to the samples recultured in Con A to ensure that any residual For GM-CSF would be neutralized. GM-CSF augmentation was observed even if the GM-CSF had been removed from cultures after only I day (Fig 4B) . In contrast, if Con A was removed from the cells at any time, almost no proliferation was measured. These results indicate that the GM-CSF-responsive cells require early delivery of the GM-CSF signal, and that delivery ofthis signal occurs within the first day of culture.
Two of the early consequences of the activation of T cells by mitogens, such as Con A or MoAb to the TCR/CD3 complex, are the upregulation of the expression of the IL- 2R on the surface of the cells and induction of the production and secretion of IL-2.36 To test if IL-2 was important in the GM-CSF-induced augmentation of thymocyte proliferation, thymocytes were stimulated with Con A or Con A plus GM-CSF in the presence and absence of anti-IL-2R MoAb hybridoma supernatant. Both the Con A and the Con A plus GM-CSF responses of the thymocytes were greatly inhibited in the presence of anti-IL-2R a chain MoAb (Fig 5A) , indicating that IL-2 is required for the maximal proliferation in the GM-CSF augmented thymocyte cultures. Although thymocyte proliferation in this system is largely IL-2-dependent. GM-CSF does not appear to act solely by inducing the production of IL-2 in the thymocyte cultures, since GM-CSF did not augment anti-CD3 MoAbinduced proliferation in the absence of IL-2 (Fig IC) , but did augment proliferation in the presence of optimal 1L-2 concentrations (data not shown). We also examined whether GM-CSF induced the upregulation of IL-2R a chain expression on the thymocytes. Although Con A did upregulate IL-2R cy chain expression ( Table 1 , experiment I), no differences were seen in the IL-2R 01 chain expression on thymocytes cultured with either Con A or anti-CD3 plus IL-2 in the presence or absence of GM-CSF. These results suggest the IL-2R N chain is upregulated in this system by the costimulus and that GM-CSF does not have an effect on this upregulation.
IL-4, IFN-7. and TNF-N have all been shown to augment thymocyte proliferation in the presence of c~mitogens.~ MoAbs to IL-4, IFN-7. and TNF-a were therefore added to thymocyte cultures supplemented with Con A and Con A plus GM-CSF to test whether any of these growth factors was required for GM-CSF augmentation of Con A-induced proliferation. In contrast to anti-IL-2R MoAb (Fig 5A) and anti-GM-CSF antiserum (Fig 2C) , none ofthese antibodies inhibited Con A plus GM-CSF-induced thymocyte proliferation (Fig 5B, C. and D) . These results suggest that IL-4, IFN-7, and TNF-cu are not involved in the GM-CSF augmentation of thymocyte proliferation.
To examine whether GM-CSF acted by recruiting additional thymocyte subsets into the response, the phenotype of thymocyte responders was determined after a 4-day culture in the presence of Con A or Con A plus GM-CSF. CD4 and CD8 expression on thymocytes stimulated with Con A and Con A plus GM-CSF was examined by flow cytometry. There was no consistent or dramatic effect of GM-CSF on the phenotype of cells after culture (data not shown). Thus, GM-CSF does not recruit additional thymocyte subsets that are distinguishable by CD4 or CD8 expression.
In summary, GM-CSF augments TCR-mediated thymocyte proliferation by acting early in the 4-day culture period. GM-CSF's effect is mediated primarily, or completely, through an IL-2-dependent pathway. However, GM-CSF augmentation does not appear to be mediated by induction of IL-2 (Fig lC) , nor does GM-CSF induce the expression of IL-2R on thymocytes (Table 1) . These results suggest that GM-CSF may not act directly on the T-lineage cells in the thymocyte population, but instead may act on ACs required for T-cell proliferation.
cffcct o f GM-CSF on thymic ACs. GM-CSF has been shown to induce effector functions of mature macrophages and dendritic cells.37 To determine whether GM-CSF-responsive ACs were present in the thymus, preincubation of AC-enriched populations was performed. The AC-enriched cells were cultured in GM-CSF or medium for 24 hours. then irradiated and cultured with freshly isolated thymocytes enriched for responder cells ( K NW-nonadherentthymocytes; a population that is not completely AC-depleted, but whose Con A response is enhanced by addition of exogenous AC cells). The Con A-induced proliferation of responders cocultured with GM-CSF-pretreated AC-enriched cells was much greater than that of responders cocultured with medium-pretreated AC-enriched cells (Fig 6) . Thus, 24-hour GM-CSF pretreatment of an AC-enriched population augmented AC activity as measured in an ACdependent proliferation assay. These results indicated that it would be necessary to completely remove thymic ACs to determine if GM-CSF could also act directly on thymic T-lineage cells. The removal of the ACs was attempted using a rigorous depletion protocol that took advantage of the adherence properties, phagocytic properties, and la expression of the ACs. The AC-depleted populations were then tested for their ability to respond to an AC-dependent stimulus. We were unable to obtain a thymocyte population in which we had completely removed the ability to respond in an AC-dependent manner, suggesting that there may be a population of thymic ACs that is very difficult to deplete. A candidate for this type of AC may be the dendritic cell. Only a few dendritic cells are required to enhance Con A-induced thymocyte p r~l i f e r a t i o n ,~~,~~ and the accessory function ofthese cells is enhanced by GM-CSF.40,4'
Efect ofGM-CSF on SP-enriched thymocytes. To analyze the effect of GM-CSF on TCR-mediated proliferation of T-lineage thymocytes, an AC-independent single-cell assay was used. In this assay, cells were plated into the wells of Terasaki plates at a concentration that maximized the frequency ofwells containing one cell, which were identified microscopically before culture. The wells were precoated with anti-CD3 MoAb to provide a multivalent matrix for TCR/CD3 cross-linking on SP thymocytes(the major TCR/ CD3-responsive population), making the cultures AC-independent. The single-cell assay distributes SP thymocytes and ACs into separate wells, so that the TCR-stimulated proliferation of the SP thymocytes occurs in the absence of any ACs. The ACs themselves are TCR/CD3-and would not be expected to proliferate in response to anti-CD3 MoAb. From the AC-dependent comitogenic assays, we knew that GM-CSF augmentation was most readily seen when the comitogen was at a suboptimal concentration (data not shown), and that thymocyte proliferation induced at suboptimal concentrations of anti-CD3 MoAb required exogenous 1L-2 (Fig IC) . In the single-cell AC-independent assay, 2 &mL of anti-CD3 MoAb and 10 U/mL of IL-2 were identified as appropriate suboptimal concentrations, at which SP thymocyte proliferation was low but consistent (data not shown). When GM-CSF was added to single-cell cultures of enriched SP thymocytes containing these suboptimal concentrations ofanti-CD3 MoAb and IL-2, GM-CSF did not aug-719 ment proliferation (Fig 7) . This is in striking contrast to the AC-dependent bulk culture assays ( Figs 1C and 2 through 5 ) in which GM-CSF augmented TCR-dependent thymocyte proliferation. These results, in conjunction with the AC preculture experiments (Fig 6) , suggest that GM-CSF augmentation ofTCR-dependent mature thymocyte proliferation is due to an augmenting effect of GM-CSF on thymic accessory cells, and not to a direct effect of GM-CSF on the mature single-positive T-lineage thymocytes themselves.
Efecl gf GM-CSF on DN-enriched thymocytes.
Although GM-CSF does not appear to act directly on mature SP thymocytes, GM-CSF has been shown to act directly on an immature T-cell line, TALL-l0 1 .l9 Consequently, we investigated whether GM-CSF is active on normal immature thymocytes. The single-cell assay was used to examine whether GM-CSF had an effect on the proliferation of the DN thymocyte subset. Most of the DN thymocytes are also negative for cell surface expression of TCR/CD3 complex. The proliferation of the DN thymocyte populations was therefore examined in the presence ofGM-CSF without any anti-CD3 MoAb costimulus.
The first DN population examined was adult DN-enriched thymocytes. This population was greater than 95% were plated at 1.6 cells/well into anti-CD3-coated wells of a Terasaki plate. The wells were examined on day 0 and theweiis with a single cell were marked. These wells were reexamined on day 5 and wells that had two or more cells were considered positive for proliferation. Anti-CD3 was used at 2 pg/mL. IL-2 was used at 10 U/mL, and GM-CSF was used at 100 U/mL. For the following culture conditions, the number of singlets scored positive/number of singlet wells examined was: IL-2 plus GM-CSF. 0/12; anti-CD3. well in the presence and absence of 100 U/mL of GM-CSF. The wells were examined on day 0, and the wells with a single cell were marked. These wells were reexamined on day 2, and wells that had two or more cells were considered positive for proliferation. These results are pooled from five experiments. For the following culture conditions, the number of singlets scored positive/number of singlet wells examined was: medium, 31 /278; and GM-CSF. 53/278. It is a coincidence that 278 singlets were examined for both medium and GM-CSF. Using the chi-square test, GM-CSF induced significant proliferation as compared with medium (P < .05). (B) Fourteen-day fetal thymocytes were plated at 1.6 cells/well in the presence and absence of 100 U/mL of GM-CSF. The wells were examined on day 0 and the wells with a single cell were marked. These wells were reexamined on day 2 and wells that had two or more cells were considered positive for proliferation. The proliferation was also examined on day 5 in some preliminary experiments.
However, no differences were seen between the day 2 and day 5 measurements, so day 2 was chosen. These results are pooled from 10 experiments. For the following culture conditions, the number of singlets scored positive/number of singlet wells examined was: medium, 94/407; and GM-CSF, 169/529. Using the chi-square test, GM-CSF induced significant proliferation as compared with medium (P < ,003).
DN as established by flow cytometry (data not shown). Furthermore, greater than 78% of the cells expressed high levels of Thy-I , indicating that these cells represent T-lineage cells (data not shown). As shown in Fig 8A, 19% of the singlecell-containing wells exhibited proliferation in the presence of GM-CSF, compared with I I % in the absence of GM-CSF. Fourteen-day fetal thymocytes were also evaluated in STEWART-AKERS ET AL this system. This population was greater than 96% DN cells (data not shown), with greater than 81% of these cells expressing intermediate to high levels of Thy-l (data not shown). indicating that these cells also represent T-lineage cells. As shown in Fig 8B, 3 2 7 of the single-cell-containing wells exhibited proliferation in the presence of GM-CSF, compared with 23% in the absence of GM-CSF. These experiments suggest that GM-CSF can directly induce proliferation of immature DN T-lineage thymocytes in the absence of a costimulus.
This may be further supported by the fact that the Thy-I cells within the DN population are very heterogenous and it is therefore unlikely that GM-CSF would be a stimulus for a significant fraction of the contaminating cell types. The immature macrophage^,^^ the mature ACS,~' and the dendritic cell^.^').^' which do express low levels of Thy-l, would not be expected to proliferate in the 2-day period of the assay. Although some proliferation of the myeloid cell types is not ruled out by our experiments, it is doubtful that myeloid cells could account for the augmented proliferation measured. Thus. the results presented in this study demonstrate that GM-CSF can stimulate mature SP thymocytes indirectly via augmentation of AC function. and suggest that GM-CSF can directly stimulate immature DN thymocytes.
DISCUSSION
GM-CSF augments TCR-mediated thymocyte proliferation. Augmentation by GM-CSF was readily seen when the comitogenic stimulus. either anti-CD3 plus IL-2 or Con A alone, was at a limiting concentration.
A brief 24-hour exposure to GM-CSF at the initiation of culture was necessary and sufficient to induce augmented thymocyte proliferation. Thymic epithelial cell lines have been demonstrated to produce not only GM-CSF,s.".12 but also GM-CSF'" and M-CSF.'" However, unlike GM-CSF, neither G-CSF nor M-CSF augmented Con A-induced thymocyte proliferation (data not shown). This suggests that among CSFs, GM-CSF specifically may play an important role in T-cell expansion.
The addition ofanti-IL-2R MoAb inhibited the response induced by both Con A and by Con A plus GM-CSF, indicating that IL-2 is necessary for thymocyte proliferation in this system. However. it is unlikely that GM-CSF is merely stimulating the production of more IL-2 in the cultures, since GM-CSF did not augment anti-CD3 MoAb-induced proliferation in the absence of exogenously added IL-2 ( Fig  IC) . but GM-CSF did augment in the presence of optimal IL-2 concentrations (data not shown). IL-7 has been shown to induce IL-2R expression on However. we found no marked differences in IL-2R cy chain expression between thymocytes stimulated with Con A and Con A plus GM-CSF, or between thymocytes stimulated with anti-CD3 plus IL-2 and anti-CD3 plus IL-2 plus GM-CSF as measured by flow cytometry ( In that study, anti-IL-7 MoAb was able to significantly inhibit thymocyte proliferation induced by IL-1 and by IL-1 plus GM-CSF. However, the reduced proliferation was still above background, suggesting that IL-l and GM-CSF may have effects other than the stimulation of IL-7 production.
To eliminate any influence of GM-CSF-activated AC on SP thymocytes, we examined SP thymocyte proliferation in an AC-independent TCR-mediated single-cell assay. In the single-cell assay, GM-CSF did not augment the proliferation of highly enriched SP cells cultured in the presence of limiting concentrations of anti-CD3 MoAb and IL-2 (Fig 7) . These results suggest that GM-CSF cannot act directly on SP thymocytes and that GM-CSF augmentation of TCRmediated thymocyte proliferation therefore occurs through the stimulation of ACs. Thus, one role of GM-CSF in the thymus may be to indirectly augment expansion of the Tlineage SP population.
A second role for GM-CSF in the thymus may be to directly induce the expansion ofthe T-lineage DN population. GM-CSF induced significant proliferation of highly enriched adult and fetal DN thymocytes in an AC-independent and TCR-independent single-cell assay (Fig 8) . Both the adult and fetal DN populations in our studies contained greater than 75% Thy-l+ cells, indicating that the majority of the cells in these populations are T lineage. A small subset of the T-lineage DN population is CD3' and expresses either yb or a@ TCR; these cells appear to be functionally mature T cells that may represent an alternate differentiation pathway to the a@ TCR/CD3+ SP T cells. The majority of T-lineage DN thymocytes are immature CD3-cells that vary in phenotype and progenitor capacity. The T-lineage DN thymocytes that most closely resemble the bone marrow precursor are in a state of rapid pr~liferation,~~ but the cytokine(s) responsible for inducing this proliferation are still unknown. The studies in this report suggest that GM-CSF should be considered as a candidate for this activity. With the recent cloning of the a chain of the murine GM-CSF re~eptor,~' it will be possible to determine which, ifany, T-lineage DN thymocytes express the high-affinity GM-CSF receptor and might proliferate in response to GM-CSF.
The DN thymocyte population also contains cells capable of myeloid differentiation, but not proliferation in response to GM-CSF. Papiernik et al demonstrated that after a 4-day culture of a CD4-CD8-Ia-Mac-1-thymocyte population with GM-CSF, cells expressing Mac-l could be detected, suggesting that macrophage differentiation had occurred. 44 In other studies, dendritic cells cultured in GM-CSF underwent a maturational process in the absence of proliferat i~n .~,~' Furthermore, thymic dendritic cells are closely associated with the thymic stromal epithelium, making it unlikely that there is a significant contamination of these cells in our thymocyte preparations.
Through the maturation of thymic macrophage and dendritic cells, GM-CSF may influence thymocyte repertoire selection during development. Thymic macrophage and dendritic cells have been shown to be important in the clonal deletion of DP thymocytes expressing self-reactive TCR.5"53 Antigen, injected intravenously, has been shown to be picked up by thymic dendritic Therefore, it is reasonable to postulate that GM-CSF plays a third role in the thymus by enhancing the ability of dendritic cells to present self-peptides and thereby influence negative selection. Thus, GM-CSF represents an important regulatory cytokine in thymocyte maturation, which may influence thymocyte differentiation at both early and late stages of T-cell development.
